Moderna

Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called... Wikipedia

  • Formerly called:  ModeRNA Therapeutics, (2010–2018)
  • Type:  Public
  • Traded as:  NASDAQ: MRNA, Nasdaq-100 component, S&P 500 component
  • ISIN:  [ ISIN: [ US60770K1079]]
  • Industry:  Biotechnology
  • Founders:  Derrick Rossi, Timothy A. Springer, Robert S. Langer, Kenneth R. Chien, Noubar Afeyan
  • Key people:  Stéphane Bancel (CEO), Noubar Afeyan (chairman), Stephen Hoge (president), David Meline (CFO)
  • Products:  Spikevax, Vaccine candidates
  • Revenue:  US$6.848 billion (2023)
  • Operating income:  US$-4.24 billion (2023)
  • Total assets:  US$18.43 billion (2023)
  • Total equity:  US$13.85 billion (2023)
  • Owners:  Stéphane Bancel (7.3%), Noubar Afeyan (5.0%), Robert S. Langer (4.0%), Stephen Hoge (1.3%)
  • Number of employees:  5,600(2023)
  • Website:  modernatx.com
  • Data source:  DuckDuckGo